...
首页> 外文期刊>Vaccine >Vaccine hesitancy around the globe: Analysis of three years of WHO/UNICEF Joint Reporting Form data-2015-2017
【24h】

Vaccine hesitancy around the globe: Analysis of three years of WHO/UNICEF Joint Reporting Form data-2015-2017

机译:疫苗在全球犹豫不决:分析了三年世卫组织/儿童基金会联合报告表格数据 - 2015-2017

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In order to gather a global picture of vaccine hesitancy and whether/how it is changing, an analysis was undertaken to review three years of data available as of June 2017 from the WHO/UNICEF Joint Report Form (JRF) to determine the reported rate of vaccine hesitancy across the globe, the cited reasons for hesitancy, if these varied by country income level and/or by WHO region and whether these reasons were based upon an assessment. The reported reasons were classified using the Strategic Advisory Group of Experts (SAGE) on Immunization matrix of hesitancy determinants (www.who.int/immunization/sage/meetings/2014/october/SAGE_working_group_revised_report_vaccine_hesitancy.pdf). Hesitancy was common, reported by &90% of countries. The list of cited reasons was long and covered 22 of 23 WHO determinants matrix categories. Even the most frequently cited category, risk-benefit (scientific evidence e.g. vaccine safety concerns), accounted for less than one quarter of all reasons cited. The reasons varied by country income level, by WHO region and over time and within a country. Thus based upon this JRF data, across the globe countries appear to understand the SAGE vaccine hesitancy definition and use it to report reasons for hesitancy. However, the rigour of the cited reasons could be improved as only just over 1/3 of countries reported that their reasons were assessment based, the rest were opinion based. With respect to any assessment in the previous five years, upper middle income countries were the least likely to have done an assessment. These analyses provided some of the evidence for the 2017 Assessment Report of the Global Vaccine Action Plan recommendation that each country develop a strategy to increase acceptance and demand for vaccination, which should include ongoing community engagement and trust-building, active hesitancy prevention, regular national assessment of vaccine concerns, and crisis response planning (www.who.int/immunizationisage/meetings/2017/october/1_GVAP_Assessment_report_web_version.pdf). (C) 2018 The Authors. Published by Elsevier Ltd.
机译:为了收集疫苗的全球疫苗犹豫不决以及如何变化,从2017年6月,从世卫组织/儿童基金会联合报告表(JRF)中提供了三年数据,以确定报告的报告率疫苗犹豫地全球犹豫不决,如果这些国家收入水平和/或世卫组织和世界卫生组织和这些原因是基于评估,那么犹豫不决的原因。报道的原因是使用专家战略咨询小组进行分类,犹豫决定因素的免疫矩阵(www.who.int/immunizate/sage/meetings/2014/october/sage_working_group_revised_report_vaccine_holsitancy.pdf)。犹豫是常见的,& 90%的国家。引用的原因清单是长期且涉及22个决定簇矩阵类别的22项。即使是最常见的类别,风险效益(科学证据,疫苗安全问题),占据所有原因所引用的不到一季度。国家收入水平,世卫组织和随着时间的推移和一个国家而异的原因。因此,基于此JRF数据,全球各国似乎了解Sage疫苗犹豫的定义并使用它来报告犹豫的原因。然而,由于仅仅超过1/3的国家,他们的原因是基于评估的原因只有超过1/3,就可以改善,其余是基于意见。关于前五年的任何评估,上部收入国家最不可能进行评估。这些分析提供了全球疫苗行动计划建议2017年评估报告的一些证据,每个国家都制定了增加疫苗接种接受和需求的战略,这应包括正在进行的社区参与和信任建设,积极犹豫的预防,定期国家评估疫苗问题和危机响应计划(www.who.int/immunizateSimare/meetings/2017/cereber/1_gvap_assessment_report_web_version.pdf)。 (c)2018年作者。 elsevier有限公司出版

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号